AMGN beat EPS expectations by 9.56%
Feb 03, 2026, 11:33 PM
0.00%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGEN (AMGN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, AMGEN's actual EPS was $5.29, beating the estimate of $4.83 per share, resulting in a 9.56% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.